Aug 2026
An indocyanine green-potentiated gastrin releasing peptide receptor-targeting multifunctional peptide-drug conjugate for prostate cancer therapy.
Prostate cancer (PCa) remains highly prevalent and deadly, and its progression to castration resistance is still difficult to treat despite recent therapeutic advances. Peptide-drug conjugates (PDCs) have emerged as promising targeted therapeutics for cancer, yet their clinical translation is hindered by unsatisfactory...
Hao Tian, Zihan Huang, Xiang-Ding Liu et al.
· Journal of Controlled Releas... · 0 citations